Skip to main content
PMC home page
Biophysical Journal logoLink to Biophysical Journal
. 1993 Dec;65(6):2383–2395. doi: 10.1016/S0006-3495(93)81312-2

Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide.

C L Shen 1, G L Scott 1, F Merchant 1, R M Murphy 1
PMCID: PMC1225979  PMID: 8312477

Abstract

beta-Amyloid protein (beta-A/4) is the major protein component of Alzheimer disease-related senile plaques and has been postulated to be a significant contributing factor in the onset and/or progression of the disease. In the senile plaque, beta-A/4 appears as bundles of amyloid fibrils. The biological activity of beta-A/4 may be related to its state of aggregation. In this work, self-assembly, fibril formation, and interfibrillary aggregation of beta(1-28), a synthetic peptide homologous with the amino-terminal fragment of beta-A/4, were investigated. The predominant form of beta(1-28) detected by size-exclusion chromatography and polyacrylamide gel electrophoresis was apparently a tetramer which does not bind Congo red. Aggregates containing cross-beta sheet structures which bind Congo red and thioflavin T were observed at concentrations of approximately 0.3 mg/ml or greater. Concentrations of 0.5-1 mg/ml were necessary for aggregation into fibrils to be detectable by classical or quasielastic light scattering. Both fibril elongation and fibril-fibril aggregation occur over the time scale investigated. The kinetics of aggregation were much faster at physiological salt concentrations than at lower ionic strength. Ionic strength also appeared to influence the morphology of the fibril aggregates. The data indicate that sample preparation method and sample history influence fibril size and number density.

Full text

PDF
2383

Images in this article

2386FIGURE 3
on p.2386
2389FIGURE 10
on p.2389

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrow C. J., Yasuda A., Kenny P. T., Zagorski M. G. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J Mol Biol. 1992 Jun 20;225(4):1075–1093. doi: 10.1016/0022-2836(92)90106-t. [DOI] [PubMed] [Google Scholar]
  2. Barrow C. J., Zagorski M. G. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. Science. 1991 Jul 12;253(5016):179–182. doi: 10.1126/science.1853202. [DOI] [PubMed] [Google Scholar]
  3. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem. 1992 Jan 5;267(1):546–554. [PubMed] [Google Scholar]
  4. Castaño E. M., Ghiso J., Prelli F., Gorevic P. D., Migheli A., Frangione B. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein. Biochem Biophys Res Commun. 1986 Dec 15;141(2):782–789. doi: 10.1016/s0006-291x(86)80241-8. [DOI] [PubMed] [Google Scholar]
  5. Chang C. T., Wu C. S., Yang J. T. Circular dichroic analysis of protein conformation: inclusion of the beta-turns. Anal Biochem. 1978 Nov;91(1):13–31. doi: 10.1016/0003-2697(78)90812-6. [DOI] [PubMed] [Google Scholar]
  6. Cotman C. W., Pike C. J., Copani A. beta-Amyloid neurotoxicity: a discussion of in vitro findings. Neurobiol Aging. 1992 Sep-Oct;13(5):587–590. doi: 10.1016/0197-4580(92)90060-b. [DOI] [PubMed] [Google Scholar]
  7. Emre M., Geula C., Ransil B. J., Mesulam M. M. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain. Neurobiol Aging. 1992 Sep-Oct;13(5):553–559. doi: 10.1016/0197-4580(92)90055-3. [DOI] [PubMed] [Google Scholar]
  8. Fraser P. E., Duffy L. K., O'Malley M. B., Nguyen J., Inouye H., Kirschner D. A. Morphology and antibody recognition of synthetic beta-amyloid peptides. J Neurosci Res. 1991 Apr;28(4):474–485. doi: 10.1002/jnr.490280404. [DOI] [PubMed] [Google Scholar]
  9. Fraser P. E., Nguyen J. T., Chin D. T., Kirschner D. A. Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. J Neurochem. 1992 Oct;59(4):1531–1540. doi: 10.1111/j.1471-4159.1992.tb08470.x. [DOI] [PubMed] [Google Scholar]
  10. Fraser P. E., Nguyen J. T., Surewicz W. K., Kirschner D. A. pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J. 1991 Nov;60(5):1190–1201. doi: 10.1016/S0006-3495(91)82154-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GEIDUSCHEK E. P., HOLTZER A. Application of light scattering to biological systems: deoxyribonucleic acid and the muscle proteins. Adv Biol Med Phys. 1958;6:431–551. doi: 10.1016/b978-1-4832-3112-9.50014-1. [DOI] [PubMed] [Google Scholar]
  12. Games D., Khan K. M., Soriano F. G., Keim P. S., Davis D. L., Bryant K., Lieberburg I. Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain. Neurobiol Aging. 1992 Sep-Oct;13(5):569–576. doi: 10.1016/0197-4580(92)90057-5. [DOI] [PubMed] [Google Scholar]
  13. Glenner G. G., Wong C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984 May 16;120(3):885–890. doi: 10.1016/s0006-291x(84)80190-4. [DOI] [PubMed] [Google Scholar]
  14. Gorevic P. D., Castano E. M., Sarma R., Frangione B. Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern. Biochem Biophys Res Commun. 1987 Sep 15;147(2):854–862. doi: 10.1016/0006-291x(87)91008-4. [DOI] [PubMed] [Google Scholar]
  15. Hilbich C., Kisters-Woike B., Reed J., Masters C. L., Beyreuther K. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J Mol Biol. 1991 Mar 5;218(1):149–163. doi: 10.1016/0022-2836(91)90881-6. [DOI] [PubMed] [Google Scholar]
  16. Hilbich C., Kisters-Woike B., Reed J., Masters C. L., Beyreuther K. Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4. Eur J Biochem. 1991 Oct 1;201(1):61–69. doi: 10.1111/j.1432-1033.1991.tb16256.x. [DOI] [PubMed] [Google Scholar]
  17. Inouye H., Fraser P. E., Kirschner D. A. Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction. Biophys J. 1993 Feb;64(2):502–519. doi: 10.1016/S0006-3495(93)81393-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Joachim C. L., Selkoe D. J. The seminal role of beta-amyloid in the pathogenesis of Alzheimer disease. Alzheimer Dis Assoc Disord. 1992 Spring;6(1):7–34. doi: 10.1097/00002093-199205000-00003. [DOI] [PubMed] [Google Scholar]
  19. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., Müller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987 Feb 19;325(6106):733–736. doi: 10.1038/325733a0. [DOI] [PubMed] [Google Scholar]
  20. Kirschner D. A., Inouye H., Duffy L. K., Sinclair A., Lind M., Selkoe D. J. Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6953–6957. doi: 10.1073/pnas.84.19.6953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Klunk W. E., Pettegrew J. W., Abraham D. J. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J Histochem Cytochem. 1989 Aug;37(8):1273–1281. doi: 10.1177/37.8.2666510. [DOI] [PubMed] [Google Scholar]
  22. Klunk W. E., Pettegrew J. W., Abraham D. J. Two simple methods for quantifying low-affinity dye-substrate binding. J Histochem Cytochem. 1989 Aug;37(8):1293–1297. doi: 10.1177/37.8.2666512. [DOI] [PubMed] [Google Scholar]
  23. Koh J. Y., Yang L. L., Cotman C. W. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 1990 Nov 19;533(2):315–320. doi: 10.1016/0006-8993(90)91355-k. [DOI] [PubMed] [Google Scholar]
  24. Koo E. H., Park L., Selkoe D. J. Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4748–4752. doi: 10.1073/pnas.90.10.4748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kowall N. W., Beal M. F., Busciglio J., Duffy L. K., Yankner B. A. An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7247–7251. doi: 10.1073/pnas.88.16.7247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kowall N. W., McKee A. C., Yankner B. A., Beal M. F. In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment. Neurobiol Aging. 1992 Sep-Oct;13(5):537–542. doi: 10.1016/0197-4580(92)90053-z. [DOI] [PubMed] [Google Scholar]
  27. Kuntz I. D., Jr, Kauzmann W. Hydration of proteins and polypeptides. Adv Protein Chem. 1974;28:239–345. doi: 10.1016/s0065-3233(08)60232-6. [DOI] [PubMed] [Google Scholar]
  28. LeVine H., 3rd Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993 Mar;2(3):404–410. doi: 10.1002/pro.5560020312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Malouf A. T. Effect of beta amyloid peptides on neurons in hippocampal slice cultures. Neurobiol Aging. 1992 Sep-Oct;13(5):543–551. doi: 10.1016/0197-4580(92)90054-2. [DOI] [PubMed] [Google Scholar]
  30. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245–4249. doi: 10.1073/pnas.82.12.4245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R. E. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci. 1992 Feb;12(2):376–389. doi: 10.1523/JNEUROSCI.12-02-00376.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. May P. C., Gitter B. D., Waters D. C., Simmons L. K., Becker G. W., Small J. S., Robison P. M. beta-Amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol Aging. 1992 Sep-Oct;13(5):605–607. doi: 10.1016/0197-4580(92)90064-5. [DOI] [PubMed] [Google Scholar]
  33. Merz P. A., Wisniewski H. M., Somerville R. A., Bobin S. A., Masters C. L., Iqbal K. Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol. 1983;60(1-2):113–124. doi: 10.1007/BF00685355. [DOI] [PubMed] [Google Scholar]
  34. Naiki H., Higuchi K., Hosokawa M., Takeda T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem. 1989 Mar;177(2):244–249. doi: 10.1016/0003-2697(89)90046-8. [DOI] [PubMed] [Google Scholar]
  35. Pike C. J., Walencewicz A. J., Glabe C. G., Cotman C. W. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur J Pharmacol. 1991 Aug 14;207(4):367–368. doi: 10.1016/0922-4106(91)90014-9. [DOI] [PubMed] [Google Scholar]
  36. Pike C. J., Walencewicz A. J., Glabe C. G., Cotman C. W. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 1991 Nov 1;563(1-2):311–314. doi: 10.1016/0006-8993(91)91553-d. [DOI] [PubMed] [Google Scholar]
  37. Podlisny M. B., Stephenson D. T., Frosch M. P., Lieberburg I., Clemens J. A., Selkoe D. J. Synthetic amyloid beta-protein fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiol Aging. 1992 Sep-Oct;13(5):561–567. doi: 10.1016/0197-4580(92)90056-4. [DOI] [PubMed] [Google Scholar]
  38. Prelli F., Castaño E., Glenner G. G., Frangione B. Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem. 1988 Aug;51(2):648–651. doi: 10.1111/j.1471-4159.1988.tb01087.x. [DOI] [PubMed] [Google Scholar]
  39. Rozemuller J. M., Eikelenboom P., Stam F. C., Beyreuther K., Masters C. L. A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol. 1989 Nov;48(6):674–691. doi: 10.1097/00005072-198911000-00009. [DOI] [PubMed] [Google Scholar]
  40. Rush D. K., Aschmies S., Merriman M. C. Intracerebral beta-amyloid(25-35) produces tissue damage: is it neurotoxic? Neurobiol Aging. 1992 Sep-Oct;13(5):591–594. doi: 10.1016/0197-4580(92)90061-2. [DOI] [PubMed] [Google Scholar]
  41. Selkoe D. J., Podlisny M. B., Joachim C. L., Vickers E. A., Lee G., Fritz L. C., Oltersdorf T. Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7341–7345. doi: 10.1073/pnas.85.19.7341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tomski S. J., Murphy R. M. Kinetics of aggregation of synthetic beta-amyloid peptide. Arch Biochem Biophys. 1992 May 1;294(2):630–638. doi: 10.1016/0003-9861(92)90735-f. [DOI] [PubMed] [Google Scholar]
  43. Waite J., Cole G. M., Frautschy S. A., Connor D. J., Thal L. J. Solvent effects on beta protein toxicity in vivo. Neurobiol Aging. 1992 Sep-Oct;13(5):595–599. doi: 10.1016/0197-4580(92)90062-3. [DOI] [PubMed] [Google Scholar]
  44. Whitson J. S., Selkoe D. J., Cotman C. W. Amyloid beta protein enhances the survival of hippocampal neurons in vitro. Science. 1989 Mar 17;243(4897):1488–1490. doi: 10.1126/science.2928783. [DOI] [PubMed] [Google Scholar]
  45. Wong C. W., Quaranta V., Glenner G. G. Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8729–8732. doi: 10.1073/pnas.82.24.8729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Yamaguchi H., Nakazato Y., Hirai S., Shoji M., Harigaya Y. Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain. Am J Pathol. 1989 Oct;135(4):593–597. [PMC free article] [PubMed] [Google Scholar]
  47. Yamaguchi H., Nakazato Y., Hirai S., Shoji M. Immunoelectron microscopic localization of amyloid beta protein in the diffuse plaques of Alzheimer-type dementia. Brain Res. 1990 Feb 5;508(2):320–324. doi: 10.1016/0006-8993(90)90416-9. [DOI] [PubMed] [Google Scholar]
  48. Yankner B. A. Commentary and perspective on studies of beta amyloid neurotoxicity. Neurobiol Aging. 1992 Sep-Oct;13(5):615–616. doi: 10.1016/0197-4580(92)90067-8. [DOI] [PubMed] [Google Scholar]
  49. Yankner B. A., Duffy L. K., Kirschner D. A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science. 1990 Oct 12;250(4978):279–282. doi: 10.1126/science.2218531. [DOI] [PubMed] [Google Scholar]
  50. Zhang S., Holmes T., Lockshin C., Rich A. Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3334–3338. doi: 10.1073/pnas.90.8.3334. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES